Study investigators expect that J&J's combo drug can extend overall survival by at least a year over the current standard of ...

Pictet Asset Management boosted its Johnson & Johnson holdings by 12.3%, adding over 155,000 shares in Q4. This raised its ...

Nearly a year after a jury decided that Johnson & Johnson should be fined just over $150 million in a lawsuit alleging that ...

Dr. Reddy's inks collaboration deal with Bio-Thera to develop and commercialize proposed biosimilar candidates of J&J's Stelara and Simponi in Southeast Asia.

Results from the COCOON study showed that Rybrevant plus Lacluze reduced grade 2 or higher dermatologic events by 50% ...

Panelists explored responsible, patient-centered use of artificial intelligence (AI) in cardiovascular care at the American ...

Shannon Sharpe joined Stephen A. Smith in piling on the LSU coach for her challenge of a student reporter after the loss to ...

To honor the conclusion of Women's History Month, we took time to talk with various leading members of Females in Mass Spectrometry (FeMS) about the importance of this month and their time with FeMS.

Eli Lilly’s lepodisiran, an investigational siRNA therapy, achieved significant and durable reductions in lipoprotein(a) ...